Comparison of standardized immunohistochemical and biochemical assays for estrogen and progesterone receptors in and yeast carcinoma

Pathology Research and Practice

Volumn 193, Issue 8, 1997, Pages 543-549

  Golouh, Rastko ^a   Vrhovec, Ivan ^a   Bračko, Matej ^a   Frković Grazio, Snježana ^a  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

Author keywords

Biochemistry; Breast carcinoma; Estrogen receptors; Immunohistochemistry; Progesterone receptors

Indexed keywords

CHARCOAL; DEXTRAN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BIOASSAY; BREAST CARCINOMA; CANCER GRADING; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY;

EID: 0030680973     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(97)80012-X     Document Type: Article

References (24)

1. Allegra JC, Lippman MC, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Aitken SC, Warren R (1980) Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer. Eur J Cancer 16: 323-331
2. Andersen J, Poulsen HS (1989) Immunohistochemical oestrogen receptor determination in paraffin-embedded tissue; prediction of response to hormonal treatment in advanced breast cancer. Cancer 64: 901-908
3. Battifora H, Mehta P, Ahn C, Esteban JM (1993) Estrogen receptor immunohistochemical assay in paraffin-embedded tissue: A better gold standard? App Immunohistochem 1: 39-45
4. Battifora H (1994) Immunocytochemistry of hormone receptors in routinely processed tissues. The new gold standard. Appl Immunohistochem 2: 143-145
5. Beck T, Weikel W, Brumm C, Wilkens C, Pollow K, Knapstein PG (1994) Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC). Gynecol Oncol 53: 220-227
6. de Mascarel I, Soubeyran, MacGrogan G, Wafflart J, Bonichon F, Durand M, Avril A, Mauriac L, Trojani M, Coindre JM (1995) Immunohistochemical analysis of estrogen receptors in 983 breast carcinomas. Concordance with biochemical assay and prognostic significance. Appl Immunohistochem 3: 223-231
7. Esteban J, Kandalaft PL, Mehta P, Odom-Maryon TL, Bacus S, Battifora H (1993) Improvement of the quantification of estrogen and progesterone receptors in paraffin-embedded tumors by image analysis. Am J Clin Pathol 99: 32-38
8. Esteban JM, Ahn C, Battifora H, Mehta P (1994) Biological significance of quantitative estrogen receptor immunohistochemical assay by image analysis in breast cancer patients. Am J Clin Pathol 102: 158-162
9. Frigo B, Scopsi L, Faber M, Gobbo M, Rilke F (1993) Application of an estrogen receptor-immunocytochemical assay primary monoclonal kit to paraffin-embedded human breast tumor tissue. Personal experience and a review of the literature. Appl Immunohistochem 2: 136-142
10. Gaskell DJ, Hawkins RA, Sangsterl K, Chetty U, Forrest AP (1989) Relation between immunocytochemical estimation of estrogen receptor in elderly patients with primary breast cancer and response to tamoxifen. Lancet i: 1044-1048
11. Golouh R, Kljun A (1995) Standardized immunohistochemistry of estrogen receptors in human breast carcinoma in routinely processed tissue. Radiol Oncol 29: 330-337
12. Hendricks JB, Stephen CA, Wilkinson EJ, Szekeres G (1996) Estrogen receptor specific (ER1D5) epitope stability in paraffin sections. J Histotech 19: 23-25
13. Hurlimann J, Gebhard S, Gomez F (1993) Estrogen receptor, progesteron receptor, pS2, ERD5, HSP27, and cathepsin D in invasive ductal breast carcinoma. Histopathology 23: 239-248
14. Katz RL, Patel S, Sneige N, Fritsche HA Jr, Hortobagyi GN, Ames FC, Brooks T, Ordonez NG (1990) Comparison of immunocytochemical and biochemical assay for estrogen receptor in fine needle aspirates and histological sections from breast carcinomas. Breast Cancer Res Treat 15: 191-203
15. Kinsel LB, Szabo E, Greene GL, Konrath J, Leight GS, McCarthy KS Jr (1989) Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: Comparison with quantitative biochemical methods. Cancer Res 49: 1052-1056
16. McGuire WL, Carl GM, Dressier LG, Owens MA (1993) Role of steroid hormone receptors as prognostic factor in primary breast cancer. Natl Cancer Inst Monogr 1: 19-23
17. MacGrogan G, Soubeyran I, de Mascarel I, Wafflart J, Bonichon F, Durand M, Avril A, Mauriac L, Trojani M, Coindre JM (1996) Immunohistochcmical detection of progesterone receptors in breast invasive ductal carcinomas. Appl Immunohistochem 4: 219-227
18. Mester J, Robertson DM, Feherty P, Kellie AE (1970) Determination of high-affinity oestrogen receptor sites in uterine supernatant preparations. Biochem J 120: 831-836
19. Nomura Y, Yamagata J, Tashiro H (1993) Steroid hormone receptors and clinical usefulness in breast cancer. Cancer 46: 2880-2883
20. Pertschuk LP, Kim DS, Nayer K, Feldman JG, Eisenberg KB, Carter AC, Rong ZT, Thelmo WL, Fleisher J, Greene GL (1990) Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival. Cancer 66: 1663-1670
21. Pertschuk LP (1996) Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222 spγ in frozen sections or cytosol-based ligand-binding assays. Cancer 77: 2514-2519
22. Shek LL, Godolphin W (1989) Survival with breast cancer: the importance of estrogen receptor quantity. Eur J Cancer Clin Oncol 25: 243-250
23. Soomro S, Shousa S, Sinnett HD (1992) Oestrogen and progesteron receptors in screen-detected breast carcinoma: an immunohistological study using paraffin sections. Histopathology 21: 543-547
24. Taylor CR (1996) Paraffin section immunohistochemistry for estrogen receptor. The time has come. Cancer 77: 2419-2422